Skip to content

Gastrointestinal Tract Microbiome in Healthy Term Infants Receiving Mother'S-own Breast Milk or Cow's Milk-based Infant Formulas

Gastrointestinal Tract Microbiome in Healthy Term Infants Receiving Mother'S-own Breast Milk or Cow's Milk-based Infant Formulas

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04059666
Enrollment
57
Registered
2019-08-16
Start date
2019-03-05
Completion date
2022-02-02
Last updated
2022-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Microbiome

Brief summary

This clinical trial will compare stool and oral microbiome composition between infants fed breast milk or one of two infant formulas for a 60 day feeding period.

Interventions

Cow's milk-based Infant Formula with whey protein-lipid concentrate

OTHERControl

Cow's milk-based Infant Formula

Sponsors

Mead Johnson Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
7 Days to 18 Days
Healthy volunteers
Yes

Inclusion criteria

* 7-18 days of age at Visit 1 * Singleton birth * Gestational age of 37-42 weeks * Birth weight of 2500 g (5 lbs 8 oz) or more * Parent or legal guardian agrees not to enroll infant in another interventional clinical study while participating in this study * Signed informed consent and use of PHI for infant and birth mother * Receipt of three protocol-compliant Baseline stool samples Infants receiving formula: * Exclusively receiving infant formula for at least 24 hours prior to randomization * Parent(s) or legal guardian has full intention to exclusively feed study formula during the study period Infants receiving human milk: * Mother has intention to exclusively provide mother's-own breast milk for the duration of the study

Exclusion criteria

* Caesarean delivery * Infant consumption of donor milk prior to randomization/registration * Maternal antibiotic use within 48 hours prior to or at time of delivery * Maternal antibiotic use while providing mother's-own breast milk to infant * Infant use of systemic antibiotics prior to randomization/registration * Any signs of an acute infection (i.e. fever, diarrhea) at randomization/registration * Weight at Visit 1 is \<95% of birth weight * Infant use of probiotics * Evidence of significant feeding difficulties * Infant was born large for gestational age * History of underlying metabolic or chronic disease or congenital malformation * Infant is immunocompromised Infants receiving human milk: * Consumption of infant formula from 1 day of age

Design outcomes

Primary

MeasureTime frameDescription
Comparison of stool microbiome between breast fed and formula fed babiesOver 60 daysStool collection

Secondary

MeasureTime frameDescription
Stool molecules at each visitOver 60 daysStool sample
24 hour recall of formula intake2 times over 60 days24 hour recall questionnaire
Oral microbiome at each visitOver 60 daysBuccal swab
Medically confirmed adverse events60 daysMedically confirmed adverse events
Stool pHOver 60 dayspH
Stool color and consistency3 times over 60 daysColor and consistency

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026